These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3534246)

  • 1. Study duration in antidepressant research: advantages of a 12-week trial.
    Quitkin FM; Rabkin JG; Stewart JW; McGrath PJ; Harrison W
    J Psychiatr Res; 1986; 20(3):211-6. PubMed ID: 3534246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidepressant specificity in atypical depression.
    Liebowitz MR; Quitkin FM; Stewart JW; McGrath PJ; Harrison WM; Markowitz JS; Rabkin JG; Tricamo E; Goetz DM; Klein DF
    Arch Gen Psychiatry; 1988 Feb; 45(2):129-37. PubMed ID: 3276282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How blind is blind? Assessment of patient and doctor medication guesses in a placebo-controlled trial of imipramine and phenelzine.
    Rabkin JG; Markowitz JS; Stewart J; McGrath P; Harrison W; Quitkin FM; Klein DF
    Psychiatry Res; 1986 Sep; 19(1):75-86. PubMed ID: 3538107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of phenelzine and imipramine in depressed inpatients.
    Davidson JR; McLeod MN; Turnbull CD; Miller RD
    J Clin Psychiatry; 1981 Oct; 42(10):395-7. PubMed ID: 7026542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyramine sulfate excretion may be a better predictor of antidepressant response than monoamine oxidase activity.
    Stewart JW; Harrison W; Cooper TB; Quitkin FM
    Psychiatry Res; 1988 Aug; 25(2):195-201. PubMed ID: 3051071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenelzine and imipramine in mood reactive depressives. Further delineation of the syndrome of atypical depression.
    Quitkin FM; McGrath PJ; Stewart JW; Harrison W; Wager SG; Nunes E; Rabkin JG; Tricamo E; Markowitz J; Klein DF
    Arch Gen Psychiatry; 1989 Sep; 46(9):787-93. PubMed ID: 2673130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind study of imipramine versus phenelzine in Melancholias and Dysthymic Disorders.
    Vallejo J; Gasto C; Catalan R; Salamero M
    Br J Psychiatry; 1987 Nov; 151():639-42. PubMed ID: 3446308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind placebo-controlled comparison of phenelzine and imipramine in the treatment of bulimia in atypical depressives.
    Rothschild R; Quitkin HM; Quitkin FM; Stewart JW; Ocepek-Welikson K; McGrath PJ; Tricamo E
    Int J Eat Disord; 1994 Jan; 15(1):1-9. PubMed ID: 8124322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenelzine v imipramine in atypical depression. A preliminary report.
    Liebowitz MR; Quitkin FM; Stewart JW; McGrath PJ; Harrison W; Rabkin J; Tricamo E; Markowitz JS; Klein DF
    Arch Gen Psychiatry; 1984 Jul; 41(7):669-77. PubMed ID: 6375621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenelzine versus imipramine in the treatment of probable atypical depression: defining syndrome boundaries of selective MAOI responders.
    Quitkin FM; Stewart JW; McGrath PJ; Liebowitz MR; Harrison WM; Tricamo E; Klein DF; Rabkin JG; Markowitz JS; Wager SG
    Am J Psychiatry; 1988 Mar; 145(3):306-11. PubMed ID: 3278631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Social functioning in chronic depression: effect of 6 weeks of antidepressant treatment.
    Stewart JW; Quitkin FM; McGrath PJ; Rabkin JG; Markowitz JS; Tricamo E; Klein DF
    Psychiatry Res; 1988 Aug; 25(2):213-22. PubMed ID: 3051072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical depression, panic attacks, and response to imipramine and phenelzine. A replication.
    Quitkin FM; McGrath PJ; Stewart JW; Harrison W; Tricamo E; Wager SG; Ocepek-Welikson K; Nunes E; Rabkin JG; Klein DF
    Arch Gen Psychiatry; 1990 Oct; 47(10):935-41. PubMed ID: 2222132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Columbia atypical depression. A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo.
    Quitkin FM; Stewart JW; McGrath PJ; Tricamo E; Rabkin JG; Ocepek-Welikson K; Nunes E; Harrison W; Klein DF
    Br J Psychiatry Suppl; 1993 Sep; (21):30-4. PubMed ID: 8217065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind crossover trial of imipramine and phenelzine for outpatients with treatment-refractory depression.
    McGrath PJ; Stewart JW; Nunes EV; Ocepek-Welikson K; Rabkin JG; Quitkin FM; Klein DF
    Am J Psychiatry; 1993 Jan; 150(1):118-23. PubMed ID: 8417553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychopharmacologic validation of atypical depression.
    Liebowitz MR; Quitkin FM; Stewart JW; McGrath PJ; Harrison W; Rabkin JG; Tricamo E; Markowitz JS; Klein DF
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):22-5. PubMed ID: 6376483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to phenelzine and imipramine in placebo nonresponders with atypical depression. A new application of the crossover design.
    Quitkin FM; Harrison W; Stewart JW; McGrath PJ; Tricamo E; Ocepek-Welikson K; Rabkin JG; Wager SG; Nunes E; Klein DF
    Arch Gen Psychiatry; 1991 Apr; 48(4):319-23. PubMed ID: 2009033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An outpatient evaluation of phenelzine and imipramine.
    Davidson J; Raft D; Pelton S
    J Clin Psychiatry; 1987 Apr; 48(4):143-6. PubMed ID: 3549705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic depression: response to placebo, imipramine, and phenelzine.
    Stewart JW; McGrath PJ; Quitkin FM; Rabkin JG; Harrison W; Wager S; Nunes E; Ocepek-Welikson K; Tricamo E
    J Clin Psychopharmacol; 1993 Dec; 13(6):391-6. PubMed ID: 8120152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of pattern analysis to identify true drug response. A replication.
    Quitkin FM; Rabkin JD; Markowitz JM; Stewart JW; McGrath PJ; Harrison W
    Arch Gen Psychiatry; 1987 Mar; 44(3):259-64. PubMed ID: 3548638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relevance of DMS-III depressive subtype and chronicity of antidepressant efficacy in atypical depression. Differential response to phenelzine, imipramine, and placebo.
    Stewart JW; McGrath PJ; Quitkin FM; Harrison W; Markowitz J; Wager S; Leibowitz MR
    Arch Gen Psychiatry; 1989 Dec; 46(12):1080-7. PubMed ID: 2686575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.